Evidence-based guidelines for the diagnosis, treatment, follow-up and prevention of the diabetic foot syndrome;Diagnostik, therapie, verlaufskontrolle und prävention des diabetischen fußsyndroms

Diabetes und Stoffwechsel

Volumn 13, Issue SUPPL. 2, 2004, Pages 9-30

  Scherbaum, W A ^a   Kiess, W ^a   Landgraf, R ^a   Morbach, S ^a   Muller E ^a   Reike, H ^a   Risse, A ^a   Spraul, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFALEXIN; CEFAZOLIN; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; DALTEPARIN; ERTAPENEM; FLUCLOXACILLIN; GENTAMICIN; GLYCOPEPTIDE; LEVOFLOXACIN; MEROPENEM; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

AMPUTATION; ARTERY DISEASE; BIOMECHANICS; DEBRIDEMENT; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEUROPATHY; HEALTH ECONOMICS; HUMAN; INFECTION; LEG REVASCULARIZATION; NEUROOSTEOARTHROPATHY; NEUROPATHY; OSTEOARTHROPATHY; PATHOPHYSIOLOGY; REHABILITATION; REVIEW; SOCIAL ASPECT; WOUND CARE;

EID: 3042626619     PISSN: 09420037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (237)

1. Abbott CA, Vileikyte L, Williamson S. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 1998;7:1071-1075
2. Ärztliche Zentralstelle Qualitätssicherung: Checkliste "Methodische Qualität von Leitlinien", Zentralstelle der Deutschen Ärzteschaft zur Qualitätssicherung in der Medizin, Köln (1999)
3. Albrektsen SB, Henriksen BM, Holstein P. Minor amputations after revascularization for gangrene. Acta Orthop Scand 1997;68(3):291-293
4. American Diabetes Association: Clinical Practice Recommendations. Diabetes Care 2002;25 (Supp 1):S69-S70
5. American Diabetes Association. Consensus Development Conference on Diabetic Foot Wound Care. Diabetes Care 1999;22:1354-1360
6. Antithrombotic Trialists Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy. BMJ 2002;324:71-86
7. Apelquvist J. Prognostic value of systolic ankle and toe blood pressure levels. Diabetes Care 1989;12:373-378
8. Apelqvist J. Wound healing in diabetes: outcome and costs. Clin Podiatr Med Surg 1998;15:21-40
9. Apelqvist J, Agardh CD. The association between clinical factors and outcome of diabetic foot ulcers. Diabetes Res Clin Pract 1992;18:43-53
10. Apelqvist J, Larsson J, Agardh CD. The importance of peripheral pulses, peripheral oedema and local pain fort he outcome of diabetic foot ulvers. Diabet Med 1990;7:590-594
11. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Int Med 1993;233:485-491
12. Apelqvist J, Larsson J, Agardh CD. Medical risk factors in diabetic patients with foot ulcers and severe peripheral vascular disease and their influence on outcome. J Diabetes Compl 1992;6:167-174
13. Apelqvist J, Castenfors J, Larsson J, Stenstrom A, Agardh CD. Wound classification is more important than site of ulceration in the outcome of diabetic foot ulcers. Diabet Med 1989;6(6):526-530
14. Apelqvist J, Castenfors J, Larsson J, Stenstrom A, Persson G. Ketanserin in the treatment of diabetic foot ulcer with severe peripheral vascular disease. Int Angiol 1990;9(2):120-124
15. Apelqvist J, Larsson J, Agardh CD, Stenström A. The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcers. J Diabetes Compl 1990;4:21-25
16. Apelqvist J, Ragnarson-Tennvall G, Larsson J, Persson U. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int 1995;16(7):388-394
17. Apelqvist J, Ragnarsson-Tennvall G, Persson U, Larsson J. Diabetic foot ulcers in a multidisciplinary setting - an economic analysis of primary healing and healing with amputation. J Int Med 1994;235:463-471
18. Arbeitsgemeinschaft Diabetischet Fuß in der Deutschen Diabetesgesellschaft. Empfehlungen zur Amputationsvermeidung beim "Diabetischen Fuß" 1993
19. Arkkila PET, Kantola IM, Viikari JSA. Limited joint mobility in non-insulin dependent diabetic (NIDDM) patients: correlation to control of diabetes, atherosclerotic vascular disease, and other diabetic complications. J Diabetes Compl 1997;11(4):208-217.
20. Armstrong DG, Boulton AJM, Banwell P. Topical negative pressure: management of complex diabetic foot wounds. The Oxford Wound Healing Society 2004
21. Armstrong DG, Dang C, Nixon BP, Boulton AJM. The hazards of the holiday foot: perons at high risk for diabetic foot ulceration may be more active on holiday. Diabet Med 2003;20:247
22. Armstrong DG, Lavery LA, Abu-Rumman P, Espensen EH, Vazquez JR, Nixon BP, Boulton AJ. Outcomes of subatmospheric pressure dressing therapy on wounds of the diabetic foot. Ostomy Wound Manage 2002;48(4):64-68
23. Armstrong DG, Lavery LA, Bushman TR. Peak foot pressures influence the healing time of diabetic foot ulcers treated with total contact casts. J Rehabil Res Dev 1998;35(1):1-5
24. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 1998;21(5):855-859
25. Armstrong DG, Lavery LA, Harkless LB. Who is at risk for diabetic foot ulceration? Clinics in Podiatric Medicine and Surgery 1998;15:11-19
26. Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg 1996;35(4):280-283
27. Armstrong DG, Lavery LA, Stern S, Harkless LB. Is prophylactic diabetic foot surgery dangerous? J Foot Ankle Surg 1996;35(6):585-589
28. Armstrong DG, Nguyen HC. Improvement in healing with aggressive edema reduction after debridement of foot infection in persons with diabetes. Arch Surg 2000;135:1405-1409
29. Armstrong DG, Nguyen HC, Laverly LA. Off-loading the diabetic foot wound: A randomised clinical trial. Diabetes Care 2001:1019-1022
30. Armstrong DG, Perales TA, Murff RT, Edelson GW, Welchon JG. Value of white blood cell count with differential in the acute diabetic foot infection. J Am Podiatr Med Assoc 1996;86:224-227
31. Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR. The natural history of acute Charcot's arthropathy in a diabetic foot speciality clinic. Diabetic Med 1997;14:357-363
32. Barnett SJ, Shield JPH, Potter MJ, Baum JD. Foot Pathology in Insulin Dependent Diabetes. Archives of Disease in Childhood 1995;73:151-153
33. Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA. Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care 1989;12(1):24-31
34. Birke JA, Rolfsen RJ. Evaluation of a Self-Administered Sensory Testing tool to Identify Patients at Risk of Diabetes Related Foot Problems. Diabetes Care 1998;21:23-25
35. Blakytny R, Jude EB, Gibson MJ, Boulton AJ, Ferguson MW. Lack of insulin-like growth factor 1 (IGF 1) in the basal ketatinocyte layet of diabetic skin and diabetic foot ulcers. J Pathol 2000;190(5):589-594
36. Bollinger M, Thordarson DB. Partial calcanectomy: an alternative to below knee amputation. Foot Ankle Int 2002;23(10):927-932
37. Borssen B, Bergenheim T, Lithner F. The epidemiology of foot lesions in diabetic patients aged 15-50 years. Diabet Med 1990;7:438-444
38. Bouter KP, Storm AJ, de Groot RR, Uitslager R, Erkelens DW, Diepersloot RJ. The diabetic foot in Dutch hospitals: epidemiological features and clinical outcome. Eur J Med 1993;2(4):215-218
39. Boulton AJM. The Pathogenesis of Diabetic Foot Problems: an Overview. DiabetMed 1996;13:S12-S16
40. Boulton AJM, Gries FA, Jervell JA. Guidelines for the Diagnosis and Outpatient Management of Diabetic Peripheral Neuropathy. Diabet Med 1998;15:508-514
41. Boulton AJM, Veves A, Young MJ. Etiopathogenesis and management of abnormal foot pressures. In: Levin ME, O'Neal LW, Bowker JH, Eds. The Diabetic Foot. 5th ed. St. Louis: Mosby Year Book; 1993:233-246
42. Boyko EJ, Ahroni JH, Stensel V. A Prospective Study of Risk Factors for Diabetic Foot Ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999;22:1036-1042
43. Breuer U. Diabetic patients compliance with bespoke footwear after healing of neuropathic foot ulcers. Diabete Metabol 1994;20:415-419
44. Brooks B, Dean R, Patel S, Wu B, Molyneaux L, Yue DK. TBI or not TBI: that is the question. Diabet Med 2001;18:528-532
45. Busch K, Chantelau E. Effectiveness of a new brand stock 'diabetic' shoes to protect against foot ulcer relapse. A prospective cohort study. Diabet Med. 2003;20(8):665-669
46. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA: Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 282 1999;15:1458-1465
47. Calle-Pascual AL, Redondo MJ, Ballesteros M. Nontraumatic lower extrernity in diabetic and nondiabetic subjects in Madrid, Spain. Diabet Metab 1997;23:519-523
48. Calle-Pascual AL, Garcia-Torre N, Moraga I. Epidemiology of nontraumatic lower extremity amputation in Area 7, Madrid, between 1989 and 1999. Diab Care 2001;24:1686-1689
49. Caputo CM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. New Engl J Med 1994;31(13):854-860
50. Caravaggi C, De Giglio R, Pritelli C, Sommaria M, Dalla Noce S, Faglia E, Mantero M, Clerici G, Fratino P, Dalla Paola L, Mariani G, Mingardi R, Morabito A. HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care 2003;26(10):2853-2859
51. Carrington AL, Abbott CA, Griffiths J, Jackson N, Johnson SR, Kulkarni J, Van Ross ER, Boulton AJ. A foot care program for diabetic unilateral lower-limb amputees. Diabetes Care 2001;24(2):216-221
52. Cavanagh PR, Ulbrecht JS, Caputo GM. The Non-Healing Diabetic Foot Wound: Fact or Fiction? Ostomy/Wound Management 1998;44 (3A)Suppl:6S-12S
53. Chantelau E, Breuer U, Leisch AC. Outpatient treatment of unilateral diabetic foot ulcers with half shoes. Diabetic Med 1993;10:267-270
54. Chantelau E, Haage P. An audit of cushioned diabetic footwear: Relation to patient compliance. Diabetic Med 1994;11:114-116
55. Chantelau E, Tanudjaja T, Altenhöfer F, Ersanli Z, Lacigova S, Metzger C. Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial. Diabet Med 1996;13:156-159
56. Claus D, Carvalho VP, Neundorfer B, Blaise JF. Perception of Vibration. Normal Findings and Methologic Aspects. Nervenarzt 1988;59:138-142
57. Connelly J, Airey M, Chell S. 2001. Variation in clinical decision making is a partial explanation for geographical variation in lower extremity amputation rates. Br J Surg 2001;88:529-535
58. Cunha BA. Antibiotic selection for diabetic foot infections: a review. J Foot Ankle Surg 2000;39:253-257
59. Dargis V, Pantelejeva O, Jonushaire A. Benefits of a Multidisciplinary Approach in the Management of Recurrent Diabetic Foot Ulceration in Lithuania. A prospective study. Diabetes Care 1999;22:1428-1431
60. Day J. Diabetic Patient Education: Determinants of Success. Diabetes Metabolism Research and Reviews 2000;16 (Suppl1):S70-S74
61. De Sonnaville JJ, Colly LP, Wijkel D, Heine RJ. The prevalence and determinants of foot ulceration in type 2 diabetic patients in a primary health care setting. Diabetes Research and Clin Pract 1997;35:149-156
62. Deutsche Gesellschaft für Gefäßchirurgie. Leitlinie zur amputationsbedrohten Extremität. Deutscher Ärzteverlag Köln, 1998
63. Ebskov LB. Epidemiology of lower limb amputation in diabetics in Denmark. Int Orthop 1991;115:285-288
64. Ebskov B, Josephsen P. Incidence of reamputation and death for gangrene of the lower extremity. Prosthet Orthot Int 1980;4:77-80
65. Edelson GW, Armstrong DG, Lavery LA, Caicco G. The acutely infected diabetic foot is not adequately evaluated in an inpatient setting. Arch Intern Med 1996;156:2373-2378
66. Edmonds ME, Blundell MP, Morris ME, Thomas EM, Cotton LT, Watkins PJ. Improved survival of the diabetic foot: the role of a specialised foot clinic. QJ Med New Series 1986;60:763-771
67. El-Shazly M, Abdet-Fattah M, Scorpiglione N. Risk factors for lower limb complications in diabetic patients. Diabetes Compl 1998;12:10-17
68. Emanuele MA, BJ Buchanan, Abraira C. Elevated leg systolic pressures and arterial calcification in diabetic occlusive vascular disease. Diabetes Care 1981;4:289-292
69. Embil JM, Papp K, Sibbald G, Tousignant J, Smiell JM, Wong B, Lau CY. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy. Wound Repair Regen 2000;8(3):162-168
70. Eneroth M, Apelqvist J, Stenstrom A. Clinical characteristics and outcome in 223 diabetic patients with deep foot infections. Foot Ankle Int 1997;18:716-722
71. Fabrin J, Larsen K, Holstein PE. Long-term Follow-Up in Diabetic Charcot Feet with Spontaneous Onset. Diabetes Care 2000;23:796
72. Faglia E, Favales F, Aldeghi A, Calia P, Quarantiello A, Oriani G, Michael M, Campagnoli P, Morabito A. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care 1996;19(12):1338-1343
73. Faglia E, Favales F, Quarantiello A. Angiographic evaluation of peripheral arterial occlusive disease and its role as a prognostic determinant for major amputation in diabetic subjects with foot ulcer. Diabetes Care 1998;4:625-630
74. Faglia E, Favales F, Morabito A. New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: a 6.5-year follow-up. Diabetes Care 2001;24(1):78-83
75. Falkenberg M. Metabolic control and amputations among diabetics in primary health care - a population-based intensified program governed by patient education. Scand J Prim Health Care 1990;8:25-29
76. Frykberg RG. Charcot Foot. An Update on Pathogenesis and Management. In: The Foot in Diabetes 3rd ed. Boulton AJM (Ed.) John Wiley & Sons Ltd. 2000;235-260
77. Frykberg RG, Mendeszoon E. Management of the Diaebetic Charcot Foot. Diabetes Metabolism Research and Reviews 2000;16 (Suppl 1):S59-S65
78. Gentzkow GD, Iwasaki SD, Hershon KS, Mengel M, Prendergast JJ, Ricotta JJ, Steed DP, Lipkin S. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996;19(4):350-354
79. Gordois A, Scuffham P, Shearer A. The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S. Diabetes Care 2003;26:1790-1795
80. Grayson ML, Gibbons GW, Habershaw GM. Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis 1994;18:683-693
81. Grayson ML, Gibbons GW, Balogh K. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995;273:721-723
82. Griffiths GD, Wieman TJ. Metatarsal head resection for diabetic foot ulcers. Arch Surg. 1990;125(7):832-835
83. Group TG. Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia. The global lower extremity amputation study group. Br J Surg 2000;87:328-337
84. Grundy SM, Garber A, Goldberg R, Havas St, Holman R, Lamendola C, Howard WJ, Savage P, Sowers J, Vega GL. Prevention Conference VI: Diabetes and Cardiovascular Disease. Writing Group IV: Lifestyle and Medical Management of Risk Factors. Circulation 2002;105:e153-e158
85. Hampson JP, Roberts RI, Morgan DA. Shared care: a review of the literature. Family Practice 1996;13:264-279
86. Hanft JR, Goggin JP. The Role of Combined Magnetic Field Bone Growth Stimulation as an Adjunct in the Treatment of Neuroarthropathy/Charcot Joint: An Expanded Pilot Study. Journal of Foot and Ankle Surgery 1998;37:510-515
87. Harding KG, Jones VP, Price P. Topical treatment: which dressing to choose. Diabet Metab Res Rev 2000;16 (Suppl.11):547-550
88. Haslbeck M, Redaelli M, Parandeh-Shab F, Neundörfer B, Stracke H, Ziegler D. Diagnostik, Therapie und Verlaufskontrolle der sensomotorischen diaberischen Neuropathien. Evidenzbasierte Diabetes-Leitlinien DDG. Scherbaum WA, Lauterbach KW, Renner R (Hrsg.). 1. Auflage. Deutsche Diabetes-Gesellschaft 2000
89. Haslbeck M, Luft D, Neundörfer B, Redaelli M, Stracke H, Wienbeck M, Ziegler D, Corvin S. Diagnose, Therapie und Verlaufskontrolle der autonomen diaberischen Neuropathie. Evidenzbasierte Diabetes-Leitlinien DDG. Scherbaum WA, Landgraf R (Hrsg.). 1. Auflage. Deutsche Diabetes-Gesellschaft 2002
90. Hayes TM, Harries JM. Randomised controlled trial of routine hospital clinic care versus routine general practice care for Type II diabetics. British Medical Journal 1984;289:728-730
91. Hayward RS, Wilson MC, Tunis SR, Bass EB, Guyatt G: Users' guides to the medical literature. VI-II: How to use clinical practice guidelines. Are the recommendations valid? The Evidence-Based Medicine Working Group. JAMA 274 (7) (1995) 570-574
92. Hehenberger K, Kratz G, Hansson A, Brismar K. Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin. J Dermatol Sci 1998;16(2):144-151
93. Heller G, Günster C, Schellschmidt H. Wie häufig sind Diabetes-bedingte Amputationen unter Extremitäten in Deutschland? Eine Analyse auf Basis von Routinedaten. Dtsch Med Wochenschr 2004;129:429-433
94. Hickman M, Drummond N, Grimshaw J. A taxonomy of shared care for chronic disease. Journal of Public Health Medicine 1994;16:447-54
95. Hilz MJ, Axelrod FB. Normative Values of Vibratory Perception in 530 Children, Juveniles and Adults Aged 3-79 Years. Journal of Neurological Science 1998;159:219-225
96. Hinman CD, Maibach HI. Effect of air exposure and occlusion on experimental human skin wounds. Nature 1963;200:377-378
97. Hirschl M, Hirschl AM. Bacterial flora in mal perforant and antimicrobial treatment with ceftriaxone. Chemotherapy 1992;38:275-280
98. Hissink RJ, Manning HA, van Baal JG. The MABAL shoe, an alternative method in contact casting for the treatment of neuropathic diabetic foot ulcers. Foot Ankle Int 2000;21:320-323
99. Holstein P. The distal blood pressure predicts healing of amputations on the feet. Acta Orthop Scand 1984;55:227-233
100. Holstein P, Ellitsgaard N, Olsen BB, Ellitsgaard V. Decreasing incidence of major amputations in people with diabetes. Diabetologia 2000;43:844-847
101. Hoskins PL, Fowler PM, Constantino M, Forrest J, Yue DK, Turtle JR. Sharing the care of diabetic patients between hospital and general practitioners: does it work? Diabet Med 1993;10:81-86
102. Humphreys W. The painful red foot-inflammation or ischemia? BMJ 1999;318:925-926
103. Hutchinson A, McIntosh A, Feder G, Home PD, Mason J, O'Keeffe C, Young R. Clinical Guidelines and Evidence Review for Type 2 Diabetes: Prevention and Management of Foot Problems London: Royal College of General Practitioners 2000
104. International Consensus Working Group: International consensus on diagnosing and treating the infected diabetic foot, 2003
105. International Consensus Working Group: Progress report: Wound Healing and Treatment of people with Diabetic Foot Ulcers. 2003
106. Internationale Arbeitsgruppe über den Diabetischen Fuß. Internationaler Consensus über den Diabetischen Fuß 1999. Mainz. Kirchheim Verlag
107. Johansson KEA, Marklund BRG, Fowelin JHR. Evaluation of a new screening method for detecting peripheral arterial disease in a primary health care population of patients with diabetes mellitus. Diabet Med 2002;19:307-310
108. Jeffcoate WJ, van Houtum WH. Amputation as a marker of the quality of foot care in diabetes. 2004;(In press)
109. Jörneskog G, Brismar K, Fagrell B. Skin Capillary Circulation is More Impaired in the Toes of Diabetic than Non-Diabetic Patients with Vascular Disease. Diabetic Medicine 1995;12:36-41
110. Jude EB, Blakytny R, Bulmer J, Boulton AJ, Ferguson MW. Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers. Diabet Med 2002;19(6):440-447
111. Jude EB, Samson O, Oyibo SO, Chalmers N, Boulton AJM. Peripheral Arterial Disease in Diabetic and nondiabetic Patients. A comparison of severity and outcome. Diabetes Care 2001;24(8):1433-1437
112. Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, Donohoe M, Foster AV, Edmonds ME, Boulton AJ. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetotogia. 2001;44(11): 2032-2037
113. Kalani M, Apelqvist J, Blomb M, Brismar K. Effect of Dalteparin on Healing of Chronic Foot Ulcers in Diabetic Patients With Peripheral Arterial Occlusive Disease, Diabetes Care 2003;26:2575-2580
114. Kallio M, Forsblom C, Groop PH, Groop L, Lepäntalo M. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diab Care 2003;26,4:1241-1245
115. Klazinga N: Compliance with practice guidelines: clinical autonomy revisited. Health Policy 1994;28:51-66
116. Klenerman L, McCabe C, Cogley D. Screening for patients at risk of diabetic foot ulceration in a general diabetic outpatient clinic. Diabet Med 1996;13:561-563
117. Kumar S, Ashe HA, Parnell LN. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population based study. Diabet Med 1994;11:480-484
118. Kumar S, Fernando DJS, Veves A. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 1991;13:63-68
119. Larsen K, Holstein PE. Stress Fractures as the Cause of Charcot Feet. In: Proceedings of the First International Symposium on the Diabetic Foot. Bakker K (Ed.). Amsterdam: Excerpta Medica 1991;108-116
120. Larsson J, Apelqvist J, Agardh CD, Stenström A. Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach? Diabet Med 1995;12:770-776
121. Larsson J, Apelqvist J, Castenfors J, Agardh CD, Stenström A. Distal blood pressure as a predictor for the level of amputation in diabetic patients with foot ulcer. Foot and Ankle 1993;14:247-253
122. Larsson J, Agardh CD, Apelqvist J, Stenstrom A. Long-term prognosis after healed amputation in patients with diabetes. Clin Orthop 1998;350:149-158
123. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998;15:157-162
124. Lavery LA, Van Houtum WH, Armstrong DG. Institutionalization following diabetes-related lower extremity amputation. Am J Med 1997;103(5):383-388
125. Lavery LA, Van Houtum WH, Harkless LB. Inhospital mortality and disposition of diabetic amputees in The Netherlands. Diabet Med 1996;13:192-197
126. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998;15:157-162
127. Levin ME. Preventing Amputation in the Patient with Diabetes. Diabetes Care 1995;18:1383-1394
128. Lee JS, Lu M, Lee VS, Russell D, Bahr C, Lee ET. 1993. Lower-extremity amputation. Incidence, risk factors, and mortality in the Oklahoma Indian Diabetes Study. Diabetes 1993;42:876-882
129. Leslie CA, Sapico FL, Ginunas VJ, Adkins RH. Randomized controlled trial of topical hyperbaric oxygen for treatment of diabetic foot ulcers. Diabetes Care 1988;11(2):111-115
130. Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997;25:1318-26
131. Lipsky BA, Baker PD, Landon GC, Fernau R. Antibiotic therapy for diabetic foot infections: comparison of two parental-to-oral regimens. Clin Infect Dis 1997;24:643-648
132. Lipsky BA, Pecoraro RE, Larson SA, Ahroni JH. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990;150:790-797
133. Litzelman DK, Marriot DJM, Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care 1997;20(8):1273-1278
134. Litzelman DK, Marriot DJM, Vinicor F. The role of footwear in the prevention of foot lesions in patients with NIDDM. Diabetes Care 1997;20:156-162
135. Litzelman D, Slemenda W, Langefeld C, Hays L, Welch A, Bild D. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. Ann of Intern Med 1993;119:36-41
136. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002;45(7):1011-1016
137. Lobmann R, Pittasch D, Muhlen I, Lehnert H. Autologous human keratinocytes cultured on membranes composed of benzyl ester of hyaluronic acid for grafting in nonhealing diabetic foot lesions: a pilot study. J Diabetes Complications 2003;17(4):199-204
138. LoGerfo FW, Coffman JD. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. New Engl J Med 1984;311:1615-1619
139. Lo Gerfo FW, Gibbons GW, Pomposelli FB Jr, Campbell DR, Miller A, Freeman DV, Quist WC. Trends in the care of the diabetic foot. Expanded role of arterial reconstruction. Arch Surg 1992;127(5):617-620
140. Macfarlane RM, Jeffcoate WJ. Factors contributing to the presentation of diabetic foot ulcers. Diabetic Med 1997;14:867-870
141. Madani SF, Stammler C, Muller UA. The frequency of lower-limb amputations in people with diabetes in the German state of Thuringia. Diabetes und Stoffwechsel 1999;8:201-206
142. Malone JM, Snyder M, Anderson G, Bernhard VM, Holloway GA, Brunt TJ. Prevention of amputation by diabetic education. Am J Surg 1989;158:520-524
143. Mantey I, Foster AV, Spencer S, Edmonds ME. Why do foot ulcers recur in diabetic patients? Diabet Med 1999;16(3):245-249
144. Marston WA, Hanft J, Norwood P, Pollak R, Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003;26(6):1701-1705
145. Martinez-de Jesus FR, Morales-Guzman M, Castaneda M, Perez-Morales A, Garcia-Alonso J, Mendiola-Segura I. Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers. Arch Med Res 1997;28(1):95-99
146. Mason J, O'Keeffe C, Hutchinson A, McIntosh A, Young R, Booth A. A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. II: treatment. Diabet Med 1999;16(11):889-909
147. Masson EA, Cooper MA, Boulton AJ. Split-skin grafting in the management of extensive neuropathic ulceration. Diabet Med 1989;6(2):171-172
148. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. Diabetic neuropathic foot ulcers: predicting which ones will not heal. Am J Med 2003;115:627-631
149. McCabe CJ, Stevenson RC, Dolan AM. Evaluation of a diabetic foot screening and protection program. Diabetic Med 1998;15:80-84
150. McCallon SK, Knight CA, Valiulus JP, Cunningham MW, McCulloch JM, Farinas LP. Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds. Ostomy Wound Manage 2000;46(8):28-32
151. McGrath NM, Curran BA. Recent commencement of dialysis is a risk factor for lower-extremity amputation in a high-risk diabetic population. Diabetes Care 2000;23(3):432-433
152. McNeely MJ, Boyko EJ, Ahroni JH. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. Diabetes Care 1995;18:216-219
153. Moore TJ, Barron J, Hutchinson F 3rd, Golden C, Ellis C, Humphries D. Prosthetic usage following major lower extremity amputation. Clin Orthop 1989;238:219-224
154. Morbach S, Mollenberg J, Quante C, Ochs H. Diabetic holiday foot syndrome - the dimension of the problem and patients' characteristics. Pract Diabetes Int 2001;18:48-50
155. Morris AD, McAlpine R, Steinke D. Diabetes and lower limb amputations in the community. A retrospective cohort study. Diabetes Care 1998;5:738-743
156. Mueller MJ, Diamond JE, Sinacore DR. Total contact casting in treatment of diabetic plantar ulcers. Controlled clinical trial. Diabetes Care 1989;12:384-388
157. Murray HJ, Young MJ, Hollis S, Boulton AJM. The Association Between Callus Formation, High Pressure and Neuropathy in Diabetic Foot Ulceration. DiabetMed 1996;13:979-982
158. Myerson M, Papa J, Eaton K. The total contact cast for management of neuropathic plantar ulceration of the foot. J Bone Joint Surg Am 1992;74A:261-269
159. O'Meara SM, Cullum NA, Majid M, Sheldon TA. Systematic review of antimicrobial agents used for chronic wounds. Br J Surg 2001;88:4-21
160. O'Meara S, Cullum N, Majid M, Sheldon T. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds, (4) diabetic foot ulceration. Health Technol Assess 2000;4:1-237
161. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Armstrong DG, Harkless LB, Boulton AJ. The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 2001;18(2):133-138
162. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJ. A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care 2001;24(1):84-88
163. Panayiotopoulos YP, Tyrrell MR, Arnold FJ, Korzon-Burakowska A, Amiel SA, Taylor PR. Results and cost analysis of distal [crural/pedal] arterial revascularisation for limb salvage in diabetic and non-diabetic patients. Diabet Med 1997;14(3):214-220
164. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990;113:516-521
165. Pellizzer G, Strazzabosco M. Presi S. "Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection." Diabet Med 2001;18:822-827
166. Peters EJ, Lavery LA, Armstrong DG, Fleischli JG. Electric stimulation as an adjunct to heal diabetic foot ulcers: a randomized clinical trial. Arch Phys Med Rehabil 2001;82(6):721-725
167. Pham H, Harkless LB, Armstrong DG. Screening Techniques to Identify People at High Risk for Diabetic Foot Ulceration. Diabetes Care 2000;23:606-611
168. Pinzur MS, Stuck RM, Sage R, Hunt N, Rabinovich Z. Syme ankle disarticulation in patients with diabetes. J Bone Joint Surg Am 2003;85-A(9):1667-1672
169. Pinzur MS, Stuck R, Sage R, Pocius L, Trout B, Wolf B, Vrbos L. Benchmark analysis on diabetics at high risk for lower extremity amputation. Foot Ankle Int 1996;17(11):695-700
170. Pittet D, Wyssa B, Herter-Clavel C, Kursteiner K, Vaucher J, Lew PD. Outcome of diabetic foot infections treated conservatively. A retrospective cohort study with long-term follow-up. Arch Intern Med 1999;159:851-856
171. Pomposelli FB Jr, Arora S, Gibbons GW, Frykberg R, Smakowski P, Campbell DR, Freeman DV, LoGerfo FW. Lower extremity arterial reconstruction in the very elderly: successful outcome preserves not only the limb but also residential status and ambulatory function. Vasc Surg 1998;28(2):215-25
172. Ragnarsson-Tennvall G, Apelqvist J. Cost-effective management of diabetic foot ulcers. PharmacoEconomics 1997;12:42-53
173. Rayman G, Malik RA, Sharma AK, Day JL. Microvascular response to tissue injury and capillary ultrastructure in the foot of type 1 diabetic patients. Clin Sc (Colch) 1995;89(5):467-474
174. Ramsey SC, Newton K, Blough D. Incidence, Outcomes, and cost of foot ulcers in Patients with Diabetes. Diabetes Care 1999;22:382-387
175. Raviola CA, Nichter LS, Baker JD, Busuttil RW, Machleder HI, Moore WS. Cost of treating advanced leg ischemia. Bypass graft vs primary amputation. Arch Surg 1988;123(4):495-496
176. Redberg RF, Greenland P, Fuster V. Prevention Conference VI. Diabetes and cardiovascular disease. Writing Group III: Risk assessment for persons with diabetes. Circulation 2002;105:e144-e152
177. Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. Diabetes in America. 2nd ed. Washington, ED: DHHS; 1995
178. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputations in patients with diabetes mellitus. A case-control study. Ann Int Med 1992;117(2):97-105
179. Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcer. Am J Surg 1998;176(suppl IIa):5-10
180. Reiber GE, Vileikyte L, Boyko EJ. Causal Pathways for Incident Lower-Extremity Ulcers in Patients With Diabetes From Two Settings. Diabetes Care 1999;22:157-162
181. Reike H. Diaberische Osteoarthroparhie und Charcot Fug. In: Diabetisches Fugsyndrom. Reike H (Ed.). Berlin: De Gruyter 1999;69-80
182. Reike H: Inhaltliche und formale Strukturen für eine erfolgreiche Betreuung von Patienten mit diabetischem Fußsyndrom. In: Reike H: Diabetisches Fußsyndrom. De Gruyrer, Berlin 1999;191-204
183. Rivers SP, Scher L, Veith FJ: Indications for distal arterial reconstruction in the presence of palpable pedal pulses. J Vasc Surg 1990;12(5):552-557
184. Rümenapf G. Grenzzonenamputation bei Diabetikern - Offene Fragen und kritische Bewertung. Zentralbl Chir 2003;128:726-733
185. Saap LJ, Falanga V. Debridement performance index and its correlation with complete closure of diabetic foot ulcers. Wound Rep Reg 2002;10:354-359
186. Sanders LJ, Frykberg RG. Diabetic neuropathic osteoarthropathy: the Charcot foot. In: The high risk foot in diabetes mellitus. Frykberg RG (Ed). New York, NY: Churchill Livingstone, 1991;297-338
187. Schömig M, Ritz E, Standl E, Allenberg J: The Diabetic Foot in the Dialyzed Patient. J Am Soc Nephrol 2000;11:1153-1159
188. Schon LC, Easley ME, Weinfeld SB: Charcot neuroarthropathy of the foot and ankle. Clin Orthop 1998;349:116-131
189. Scottish Intercollegiate Guidelines Network: SIGN Guidelines. An introduction to SIGN methodology for the development of evidence-based clinical guidelines (1999)
190. Second European Consensus Document on Chronic Critical Ischaemia. Eur J
191. Selby PL, Young MJ, Boulton AJM. Bisphosphonates: A new treatment for diabetic Charcot neuroarthropathy? Diabet Med 1994;11:28-31
192. Senneville E, Yazdanpanah Y, Cazaubiel M. Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J Antimicrob Chemotherap 2001;48:927-930
193. Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 2003;26(6):1879-1782
194. Sherman RA. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy. Diabetes Care 2003;26:446-451
195. Siancore DR, Mueller MJ, Diamond JE, Blair VP, Drury D, Rose SJ. Diabetic plantar ulcers treated by total contact casting. Physical therapy 1987;67:1543-1549
196. Smith FC, Shearman CP, Simms MH, Gwynn BR. Falsely elevated ankle pressures in severe leg ischaemia: the pole test - an alternative approach. Eur J Vasc Surg. 1994;8(4):408-412
197. Smith J. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev 2002;(4):CD003556
198. Spraul M. Prävention des diabetischen Fugsyndroms. Internist 1999;40:1056-1066
199. Spraul M, Schönbach AM, Mühlhauser I, Berger M. Amputationen und Mortalität bei älteren, insulinpflichtigen Patienten mit Typ 2-Diabetes. Zentralbl Chir 1999;124:25-31
200. Steed DL, Donohue D, Webster M, Lindsey L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. J Am Coll Surg 1996;183:61-64
201. Stiegler H, Standl E, Frank S, Mendler G. 1998. Failure of reducing lower extremity amputations in diabetic patients: results of two subsequent population based surveys in 1990 and 1995 in Germany. Vasa 1998;27:10-14
202. Striesow F. Konfektionierte Spezialschuhe zur Ulkusrezidivprophylaxe beim diabetischen Fußsyndrom. Med Klein 1998;93:695-700
203. Sumpio BE. Foot Ulcers. New Engl J Med 2000;343,11:787-793
204. Tentolouris N, Jude EB, Smirnof I, Knowles EA, Boulton AJM. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med 1999;16:767-771
205. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of Radiographic-Contrast-Agent-Induced Reductions in Renal Function by Acetylcysteine. N Engl J Med 2000;343:180-184
206. Thomas S, Jones M, Shutler S, Jones S. Using larvae in modern wound management. J Wound Care 1996;5:60-69
207. The LEA Study Group. Comparing the incidence of lower extremity amputations across the world: the global lower limb extremity amputation study. Diabetic Med 1995;12:14-18
208. Thivolet C, El Farkh J, Petiot A. Measuring vibration sensations with graduated tuning fork: simple & reliable means to detect diabetic patients at risk of neuropathic foot ulceration. Diabetes Care 1990;13(10):1077-1080
209. Thompson C, McWilliams T, Scott D, Simmons D. Importance of diabetic foot admissions at Middle-more Hospital. N Z Med J 1993;12;106(955):178-180
210. Tooke JE, Brash PD. Microvascular Aspects of Diabetic Foot Disease. Diabet Med 1996;13:S26-S29
211. Trautner C, Standl E, Haastert B, Giani G, Berger M. Geschätzte Anzahl von Amputationen in Deutschland. Diabetes und Stoffwechsel 1997;6:199-202
212. Trautner C, B Haastert, M Spraul, G Giani, M Berger. Unchanged incidence of lower-limb amputations in a German city, 1990-1998. Diabetes Care 2001;24:855-859
213. Uccioli L, Aldeghi A, Faglia E. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995;18:1376-78
214. Van der Feen C, Neijens FS, Kanters SDJM, Mali WPTHM, Stolk RP, Banga JD. Angiographic distribution of lower extremity atherosclerosis in patients with and without diabetes. Diabet Med 2002;19:366-370
215. Van Gils CC, Wheeler LA, Mellstrom M, Brinton EA, Mason S, Wheeler CG. Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients. The Operation Desert Foot experience. Diabetes Care 1999;22:678-683
216. Van Houtum WH, Lavery LH. Outcomes associated with diabetes-related amputations in the Netherlands and the State of California. J Int Med 1996;240:227-231
217. Van Houtum WH, Lavery LA, Harkless LB. The costs of diabetes-related lower extremity amputations in the Netherlands. Diabet Med 1995;12(9): 777-781
218. Van Houtum WH, Lavery LH, Harkless LB. The impact of diabetes-related lower extremity amputations in the Netherlands. J Diabetes Compl 1996;10:325-330
219. Vazquez JR, Short B, Findlow AH, Nixon BP, Boulton AJ, Armstrong DG. Outcomes of hyaluronan therapy in diabetic foot wounds. Diabetes Res Clin Pract 2003;59(2):123-127
220. Venkatesan P, Lawn S, Macfarlane RM, Fletcher EM, Finch RG, Jeffcoate WJ. Conservative management of osteomyelitis in the feet of diabetic patients. Diabet Med 1997;14:487-490
221. Veves A, Falanga V, Armstrong DG, Sabolinski ML, Apligraf Diabetic Foot Ulcer Study. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001;24(2):290-295
222. Veves H, Masson EA, Fernando DFS, Boulton AJM. Use of experimental padded hosiery to reduce abnormal foot pressure in diabetic patients. Diabetes Care 1989;12:653-655
223. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg. 2002;137(7):822-827
224. Vileikyte L, Hutchings G, Hollis S. The tactile circumferential discriminator: A new, simple screening device to identify diabetic patients at risk of foot ulceration. Diabetes Care 1997;20(4):623-626
225. Wagner AH, Reike H, Angelkort B. Highly resistant pathogens in patients with diabetic foot syndrome with special reference to methicillin-resistant Staphylococcus aureus infections. Dtsch Med Wochenschr 2001;126:1353-1356
226. Wagner FW. The Dysvascular foot: A system for diagnosis and treatment. Foot and Ankle 19812:64-122
227. Walters DA, Gatling W, Mullee MA. The distribution and severity of diabetic foot disease: a community based study with comparison to a non-diabetic group. Diabetic Med 1992;9:354-358
228. Wheat LJ, Allen SD, Henry M, Diabetic foot infections. Bacteriologic analysis. Arch Intern Med 1986;146:1935-40
229. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 1998;21(5):822-827
230. Winter GD. Formation of the scab and the rate of epithelization of superficial wound in the in the skin of young domestic pig. Nature 1962;193:293-294
231. Wissenschaftliches Institut der AOK, Presseinformation 12.2.2003, www.wido.de
232. Wunderlich RP, Peters EJ, Lavery LA. Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot. Diabetes Care 2000;23 (10):1551-1555
233. Yeager RA, Moneta GL, Edwards JM, Williamson WK, McConnell DB, Taylor LM Jr, Porter JM. Predictors of outcome of forefoot surgery for ulceration and gangrene. Am J Surg. 1998;175(5):388-390
234. Young M, Boulton AJM. A Multicentre Study of the Prevalence of Diabetic Peripheral Neuropathy in the United Kingdom Hospital Clinic Population. Diabetologia 1993;36:150-154
235. Young MJ, Breddy JL, Veves A, Boulton AJM. The prediction of neuropathic foot ulceration using vibration perception thresholds. Diabetes Care 1994;17:557-561
236. Young MJ, Cavanagh PR, Thomas G, Johnson MM, Murray H, Boulton AJM. The effect of callus removal on dynamic foot pressures in diabetic patients. Diabetic Med 1992;9:55-57.
237. Zimny S, Schatz H, Pfohl M. Determinants and estimation of healing times in diabetic foot ulcers. J Diabetes Compl 2002;16(5):327-332